These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 83257)

  • 1. Sex steroids and thyroid function tests: the role of estrogen and progestogen.
    Miyamoto J
    Int J Gynaecol Obstet; 1978; 16(1):28-33. PubMed ID: 83257
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of oral contraceptives and pregnancy on thyroid function.
    Schatz DL; Palter HC; Russell CS
    Can Med Assoc J; 1968 Nov; 99(18):882-6. PubMed ID: 4177069
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
    Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral contraceptives and thyroid function tests.
    Winikoff D; Taylor K
    Med J Aust; 1966 Jul; 2(3):108-12. PubMed ID: 4161196
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemostatic system changes induced by 50 micrograms and 30 micrograms estrogen/progestogen oral contraceptives. Modification of estrogen effects by levonorgestrel.
    Sabra A; Bonnar J
    J Reprod Med; 1983 Jan; 28(1 Suppl):85-91. PubMed ID: 6834350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potency of progestogens in oral contraceptives--further delay of menses data.
    Swyer GI
    Contraception; 1982 Jul; 26(1):23-7. PubMed ID: 7128131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electroencephalographic changes during long term treatment with oral contraceptives.
    Matsumoto S; Sato I; Ito T; Matsuoka A
    Int J Fertil; 1966; 11(2):195-204. PubMed ID: 4163250
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Radioimmunological study of the effect of hormonal contraceptives upon the progesterone level of saliva (author's transl)].
    Arnold M; Tóth I; Faredin I
    Zahn Mund Kieferheilkd Zentralbl; 1980; 68(7):713-8. PubMed ID: 6163264
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex hormone binding globulin: effect of synthetic steroids on the assay and effect of oral contraceptives.
    Bowles SM; Mills RJ
    Ann Clin Biochem; 1981 Jul; 18(Pt 4):226-31. PubMed ID: 7197136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the effect of oral contraceptives, pregnancy and sex on iron metabolism.
    Mardell M; Symmons C; Zilva JF
    J Clin Endocrinol Metab; 1969 Nov; 29(11):1489-95. PubMed ID: 4186910
    [No Abstract]   [Full Text] [Related]  

  • 13. [The behavior of the gonadotropins FSH and LH during and after treatment with estrogenic and progestational drugs].
    Ramadori P; Lirosi G
    Patol Clin Ostet Ginecol; 1973; 1(1):26-34. PubMed ID: 4143256
    [No Abstract]   [Full Text] [Related]  

  • 14. Thyroid function tests during pregnancy, the normal menstrual cycle and in women using oral contraceptives.
    Standeven RM
    J Endocrinol; 1969 Feb; 43(2):217-24. PubMed ID: 4180278
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of oral contraceptive steroids on jejunal pyruvate kinase and adenyl cyclase activities.
    Stifel FB; Greene HL; Herman RH
    Endocrinology; 1971 Sep; 89(3):896-7. PubMed ID: 4105307
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma triglyceride turnover during use of oral contraceptives.
    Kekki M; Nikkilä EA
    Metabolism; 1971 Sep; 20(9):878-89. PubMed ID: 4105291
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral contraceptive estrogen and plasma lipid levels.
    Hedlin A; Kuksis A; Geher K
    Obstet Gynecol; 1978 Oct; 52(4):430-5. PubMed ID: 714324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oestrogen containing oral contraceptives and antithrombin III activity.
    Rákóczi I; Nagy I; Szigetvári I; Losonczy H; Hadnagy J; Gáti I
    Acta Physiol Acad Sci Hung; 1974; 45(3-4):281-6. PubMed ID: 4471272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone mineral: effects of oral contraceptives, pregnancy, and lactation.
    Goldsmith NF; Johnston JO
    J Bone Joint Surg Am; 1975 Jul; 57(5):657-68. PubMed ID: 1150709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbohydrate metabolism during treatment with estrogen, progestogen, and low-dose oral contraceptives.
    Spellacy WN
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):732-4. PubMed ID: 7039318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.